Related Experiment Videos
Chymase inhibitors may prevent postoperative adhesion formation
Yukiko Okamoto1, Shinji Takai, Mayumi Yamada
1Department of Pharmacology, Osaka Medical College, Takatsuki City, Osaka, Japan.
Fertility and Sterility
|May 16, 2002
Summary
Mast cell chymase significantly contributes to postoperative adhesion formation. A specific chymase inhibitor effectively reduced adhesion scores in a hamster model, suggesting its therapeutic potential.
Area of Science:
- Biochemistry
- Surgical Research
- Pharmacology
Background:
- Mast cells are implicated in inflammatory processes.
- Chymase, an enzyme released by mast cells, is suspected to play a role in tissue remodeling and adhesion formation.
- Postoperative adhesions are a significant cause of morbidity.
Purpose of the Study:
- To elucidate the role of mast cell-derived chymase in the development of postoperative adhesions.
- To evaluate the efficacy of a novel chymase inhibitor in preventing adhesion formation.
Main Methods:
- A prospective randomized study was conducted using a surgical model of adhesion formation in 67 female Syrian hamsters.
- A uterine lesion was created, followed by abdominal injection of either a chymase inhibitor (Suc-Val-Pro-Phe(p)(OPh)(2)) or a placebo.
- Chymase activity in uterine tissues was measured at 3 days, and adhesion formation was scored at 2 weeks post-surgery.
Main Results:
- Chymase activity in the injured uterus was significantly elevated but reduced by the chymase inhibitor treatment.
- Adhesion formation scores were significantly lower in the group treated with the chymase inhibitor compared to the placebo group.
Conclusions:
- Mast cell chymase is a key factor in the pathogenesis of postoperative adhesion formation.
- Chymase inhibitors demonstrate potential as a therapeutic strategy for preventing adhesions.